Researchers hack the metastatic process using nanoparticles
Memorial Sloan Kettering Cancer Center (MSK) molecular pharmacologist Daniel Heller, PhD, and colleagues have identified a new strategy to target drugs specifically to cancer sites, including metastatic tumors. The approach ...
Jul 6, 2016
0
46